Engineered cells are humanity’s next leapfrog in healthcare.
But right now patient access is limited.

MFX presents the Cyto Engine™, the fastest, automated, instantly scalable platform for cell and gene therapy manufacture to help the commercialization and clinical translation of life-saving medicines.